LDS/Medical Tests/Lysergic Acid Diethylamide, Urine

Lysergic Acid Diethylamide, Urine

Lysergic acid diethylamide (LSD) is a semisynthetic psychedelic drug of abuse known for its strong hallucinogenic properties. It was originally introduced as a psychiatric medication (Delysid), and was considered in the 1950s for use in military-facilitated "mind control." The d-isomer is one of the most potent hallucinogenic agents known. Visual changes and mood alterations precede hallucinatory symptoms that include distorted perception of the size, shape, color, position and movement of the objects and disorientation to time, place and person. The typical route of administration is oral. The half-life of LSD is 3-4 hours. Only <1% being excreted in the urine in unchanged form, which remains detectable for a very short period of time (10-12 hours after ingestion). However, 2-oxo-3-hydroxy LSD (O-H-LSD), a metabolite of LSD, has a longer half-life and hence is a reliable surrogate marker of LSD abuse.

The concentration of O-H-LSD is significantly higher than LSD (up to 43 times that of the parent drug). *Iso*-LSD is an isomer of LSD and is formed during the illicit synthesis of LSD from lysergic acid. LSD can be detected in urine by a variety of analytical methods (see below); both qualitative and quantitative tests are available.

  • Drug abuse evaluation
  • Toxicity/Overdose assessment
A qualitative positive result indicates only the presence of LSD and does not necessarily correlate with the extent of physiological and psychological effects, nor does it predict the dose that was taken or administered. Any result that is inconsistent with clinical expectations should be confirmed or quantitated by a second method.

Negative

Note: therapeutic ranges and toxic thresholds are best evaluated from blood samples. Quantitative results obtained with blood samples collected at specific times after drug administration is preferred for pharmacokinetic analyses.

Cut-Off Ranges
Cut-off values are used to determine the positivity of the urine specimen being analyzed. Cut-off values can vary based on the particular method of analysis that is used for detection or laboratory, or whether the test is a qualitative method or a quantitative method. Detection will be improved with low cutoff concentrations. The testing laboratory cut-off range is listed on the patient report.

Liquid Chromatography/Mass Spectroscopy (LC/MS, LC-MS/MS), Gas Chromatography/Mass Spectroscopy (GC/MS), Thin Layer Chromatography (TLC), or Immunoassay (IA).

Fresh urine specimen (random) collected in either a clean glass or plastic container. An acceptable urine specimen submitted for testing should be in the pH range of 3-11. Creatinine or specific gravity results will identify dilute specimens. Adulteration of the urine specimen can result in erroneous results. Specimens should be Protect from light.

Stability

  • Ambient 5 days
  • Refrigeration 7 days
  • Frozen 30 days
Supportive testing such as a liver profile, kidney profile, comprehensive metabolic panel, CBC, and testing for concomitant drugs may be appropriate.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Clin Chem. 1998 Feb;44(2):287-92 [PMID: 9474026]
  • J Anal Toxicol. 2009 Jun;33(5):253-9 [PMID: 19671244]
  • J Anal Toxicol. 2000 Apr;24(3):170-9 [PMID: 10774536]
  • J Anal Toxicol. 1997 May-Jun;21(3):181-4 [PMID: 9171199]
  • Baselt RC (ed). Disposition of toxic drugs and chemicals in man, 9th ed. Foster City, CA: Biomedical Publications; 2011.